Vaccination coverage

COVER (Cover of Vaccination Evaluated Rapidly)

The COVER programme monitors immunisation coverage data for children in the UK who reach their first, second or fifth birthday during each evaluation quarter.

Vaccination coverage statistics are prepared each quarter from the Northern Ireland Child Health System.

Vaccination coverage for the completed primary vaccination programme is assessed when the child is 12 and 24 months of age. Children are routinely scheduled at 2, 3 and 4 months of age for diphtheria, tetanus, pertussis, polio and haemophilus influenzae type b vaccine (DTaP/IPV/Hib), meningococcal serogroup C conjugate vaccine (MenC) and pneumococal vaccine (PCV).

A booster dose of Hib and MenC vaccine (given as a combined Hib/MenC vaccine) is scheduled at around 12 months, and measles, mumps and rubella (MMR) and PCV booster vaccine at around 13 months.

Children are scheduled to receive preschool (aged 3-5 years), diphtheria, tetanus, pertussis and polio (DTaP/IPV) booster vaccine and second dose MMR vaccine. Therefore, vaccine coverage is also measured at the child's fifth birthday.

Data June 2018

12 months of age.pdf

24 months of age.pdf

5 years of age.pdf

PHE coverage data

HPV Immunisation Programme

In the UK, all 12-13 year old girls are offered HPV vaccination through the national HPV immunisation programme. From September 2008 until August 2012 the programme used the bivalent HPV vaccine (CervarixTM, GlaxoSmithKline) that protects girls against infection with HPV 16 and 18 (associated with over 70% of cervical cancers in the UK). From September 2012, 12-13 year old girls are offered the quadrivalent vaccine (Gardasil, Sanofi Pasteur MSD) which protects against types 16 and 18 and also against types 6 and 11 (associated with the majority of genital warts). From September 2014 the programme will change from a three to a two dose schedule.

Annual HPV vaccination coverage statistics are prepared from the Northern Ireland child Health System. 






PHE HPV data.
HPV data